©2024 Stanford Medicine
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Not Recruiting
Trial ID: NCT01516398
Purpose
A lung condition called bronchopulmonary dysplasia (BPD) is a major cause of poor outcomes
and death for premature infants. Infants with BPD are also at high risk for pulmonary
hypertension (PH)-an important contributor to their condition. Previous research has
suggested that a protein in the blood, endothelin-1 (ET-1), is associated with pulmonary
disease.
This study aims to investigate the incidence of PH and levels of ET-1 among premature babies
with BPD. It will also potentially allow us to focus further research efforts and treatment
towards these infants, some of our sickest patients at LPCH.
Official Title
Endothelin-1 (ET-1) Levels as Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia (BPD)
Stanford Investigator(s)
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Christine Johnson, MD
650 723-5711